Molina Healthcare (MOH) Schedules Q3 2026 Earnings Release for October 21

Molina Healthcare Inc. (NYSE: MOH) has confirmed it will release its third‑quarter 2026 earnings after market close on Wednesday, October 21, 2026. A conference call and webcast to discuss the results are scheduled for the following morning, Thursday, October 22, at 8:00 a.m. Eastern Time. A replay will be available through October 29, and an online replay will be posted shortly after the live call concludes.

This upcoming earnings release marks a key date for investors to assess Molina’s performance through the third quarter, especially amid evolving pressures across Medicaid, Medicare, and state marketplace segments. The earnings release and call schedule were announced in early September through a Business Wire release published by Molina Healthcare’s investor relations team.

As of October 6, 2026, Molina Healthcare’s share price stands at $195.17, representing a modest intraday gain of +0.26%. Investors will be closely watching the Q3 results for guidance trends, segment performance, and management commentary on key cost pressures or membership trends.

This third‑quarter earnings event offers an opportunity to benchmark against the company’s second‑quarter updates in July. At that time, Molina posted GAAP diluted EPS of $1.19 and adjusted EPS of $1.51, and raised full‑year 2026 adjusted earnings guidance to at least $5.25 per share. Premium revenue declined year‑over‑year, while operating cash flow improved markedly due to favorable timing of government receivables and payables.

Investors should monitor whether trends such as state Medicaid contract dynamics or marketplace membership hold steady, especially as Molina recently highlighted a strategic exit from traditional MAPD products for 2027 and implementation of a new Florida Medicaid contract expected to impact earnings in Q4.

In summary, Molina Healthcare’s scheduled Q3 earnings announcement on October 21, followed by a conference call on October 22, positions investors to closely evaluate the company’s financial trajectory amid ongoing managed care sector volatility.